Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

Nature Medicine

Volumn 5, Issue 7, 1999, Pages 839-842

  Mutis, Tuna ^a   Gillespie, Geraldine ^b   Schrama, Ellen ^a   Falkenburg, J H Frederik ^a   Moss, Paul ^c   Goulmy, Els ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN ANTIBODY REACTION; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; MACROMOLECULAR SUBSTANCES; MINOR HISTOCOMPATIBILITY ANTIGENS; MONITORING, IMMUNOLOGIC; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

CHORIOMENINGITIS VIRUS; HUMAN HERPESVIRUS 4; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 0033028792     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/10563     Document Type: Article

References (24)

1. Horowitz, M.M. et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-62 (1990).
2. Goulmy, E., Gratama, J.W., Blokland, E., Zwaan, F.E. & van Rood, J.J. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 302, 159-161 (1983).
3. Goulmy, E. Human minor histocompatibility antigens. Curr. Opin. Immunol. 8, 75-81 (1996).
4. Goulmy, E. et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334, 281-285 (1996).
5. Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996).
6. MuraliKrishna, K. et al. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8, 177-118 (1998).
7. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187, 1395-1402 (1998).
8. Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383-1393 (1998)
9. den Haan, J.M. et al. Identification of a Graft-versus-Host Disease-associated human minor Histocompatibility antigen. Science 268, 1476-1480 (1995).
10. den Haan, J.M. et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single aminoacid polymorphism. Science 279, 1054-1057 (1998).
11. Wang, W. et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269, 1588-1590 (1995).
12. Meadows, L. et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6, 273-281 (1997).
13. + T cell subsets. Blood 82, 298-306 (1993).
14. Schwarer, A.P. et al. Frequency of anti-recipient alloreactive T-cell precursors in donor blood after HLA identical sibling bone marrow transplantation. Lancet 341, 203-205 (1993).
15. de Bueger, M., Bakker, A., Bontkes, H., van Rood, J.J. & Goulmy, E. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with CVHD. Bane Marrow Transplant. 11, 363-368 (1993).
16. van Els, C.A. et al. Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells. Transplantation 50, 62-66 (1990).
17. Liem, L.M., van Noort, J.T. & Goulmy, E. Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A. Bone Marrow Transplant. 18, 73-78 (1996).
18. Hamilton, B.L. Absence of correlation between cytolytic T lymphocytes and lethal murine graft-versus-host disease in response to minor histocompatibility antigens. Transplantation 38, 357-360 (1984).
19. Tsoi, M.S., Storb, R., Dobbs, S., Medill, L. & Thomas, E.D. Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease. J. Immunol. 125, 2258-2262 (1980).
20. Niederwieser, D. et al. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 81, 2200-2208 (1993).
21. Gratwohl, A. et al. Delayed and divergent effects of anti-HY minor histocompatibility antigen reactivity after allogeneic BMT for CML. Abstract (#1312). Blood 92 Supplement 1, 320a (1998).
22. Zarozinski, C.C. & Welsh, RM. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J. Exp. Med. 185, 1629-1639 (1997).
23. Ehl, S., Hombach, J., Aichele, P., Hengartner, H. & Zinkernagel, RM. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 185, 1241-1251 (1997).
24. Wilke, M., Pool, J., den Haan J.M. & Goulmy. E. Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens 52, 312-317 (1998).